Garry Arthur Neil - Chief Executive Officer at Avalo Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Executive Officer
Stock Symbol
AVTX on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Garry Arthur Neil since 4/22/2024

Holdings reported by Garry Arthur Neil for Avalo Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Restricted Stock Units 130K $1.69M $13.00 Mar 28, 2025 Direct Common Stock
Common Stock 47.1K $399K $8.46 Mar 28, 2025 Direct
Stock Option (Right to Buy) 411K Jan 28, 2025 Direct Common Stock

Transactions reported by Garry Arthur Neil for Avalo Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.